What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach

Size: px
Start display at page:

Download "What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach"

Transcription

1 What s the diff with C. diff.? Accelerating Prevention Using a Bundle Approach GHA Learning & Action Network - 01/13/16 Russ Olmsted Dir., Infection Prevention & Control (IPC) System Office, Livonia olmstedr@trinity-health.org 2014 Trinity Health. All Rights Reserved. 1

2 Objectives & Disclosures 1.Describe the epidemiology of C. difficile infection (CDI) in the U.S. 2. Understand the pathogenesis of CDI. 3. List at least one strategy to prevent CDI 4. Describe elements of a bundle of prevention strategies to prevent CDI.. R. Olmsted is a member of a Speakers Bureau sponsored by Ethicon, Inc. & consultant to Premier Inc. s Safety Institute 2014 Trinity 2014 Health. Trinity All Health Rights - Livonia, Reserved. MI 2

3 Antibiotic Associated Pseudomembranous Colitis Due to Toxin-Producing Bacteria Bartlett and co-workers 1 demonstrated cytotoxicity in tissue culture and enterocolitis in hamsters from stool isolates from patients with pseudomembranous colitis Isolate was C. difficile Bacillus difficilis (now confirmed as C. difficile) was cultured from healthy neonates (with difficulty, hence the name) in Bartlett JG, et al. NEJM. 1978;298: Hall JC and O Toole E. Am J Dis Child. 1935;49: Trinity Health. All Rights Reserved. 3

4 Morbidity & Mortality Associated with C. difficile infection (CDI) business case for prevention Lessa FC, et al. N Engl J Med 2015;372: Trinity Health. All Rights Reserved. 4

5 Discharge rate for Clostridium difficile infection from US short-stay hospitals by age Fernanda C. Lessa et al. Clin Infect Dis. 2012;55:S65-S70

6 Building the Case for Prevention in the Community; experience in GA with CDI Reddy S. GA Emerging Infection Program, 3/27/ Trinity Health. All Rights Reserved. 6

7 Ongoing Microbial Challenges: C. difficile infection, 2011, U.S. Estimated no. of deaths = 29,300 Lessa FC et al. N Engl J Med 2015;372: Trinity Health. All Rights Reserved. 7

8 Experience with CDI in Long Term Care Setting 122 VA LTCFs, U.S. Pooled rate = 1.98/10k Res. Days CDI Bundle: i)ppe + Cont Prec ii)hand Hyg. iii)env. cleaning & Disinfection iv) ASP Long-term care facility onset Lab ID rate = 50% decline. Clinically confirmed facility onset rate also declined but not statistically significant. Reason? Culls test results of those who are asymptomatic. Reeves JS, et al. Infect Control Hosp Epidemiol 2015 (Dec);first view article 2014 Trinity Health. All Rights Reserved. 8

9 SPECIAL CHALLENGES IN INFECTION CONTROL; CMS state operations manual, rev. 122, 9/26/14 Multidrug-resistant organisms (MDROs) Ambulatory Care Communicable disease outbreaks Bioterrorism Antimicrobial stewardship new in Trinity 2014 Health. Trinity All Health Rights - Livonia, Reserved. MI 9

10 New Standard on ASP? Timely support for CDI Prevention and Control ; comments due 12/30/ Trinity Health. All Rights Reserved. 10

11 New Frontier for ASP? implementation of outpatient interventions to reduce inappropriate antibiotic use could substantially decrease CA-CDI rates Oral penicillins and β-lactams with increased activity (amoxicillin/clavulanic acid), 2 antibiotic classes with greatest potential for declines in CA-CDI rates... Dantes R, et al. Open Forum Infectious Diseases Trinity Health. All Rights Reserved. 11

12 Risk Factors for Infection Hospitalization or long-term care facility Antibiotics (some more than others) Other medication exposure: chemotherapy, immunosuppressants, proton pump inhibitors Increasing age (>65, >>80) Co-morbidities Surgery Community-associated cases Peri-partum Close contact of CDI (C. difficile infection) case Food? 2014 Trinity Health. All Rights Reserved. 12

13 Outcomes of CDI Increases length of stay by days. Attributable costs of inpatient CDI in 2008 dollars = $3,006 $15,397 per episode. Patients with CDI were almost 2x as likely to be discharged to a long-term care facility Attributable mortality = 5% 10% Colonization of healthy non-hospitalized adults is uncommon (ie, rate <5%), however among hospitalized patients and especially nursing home residents range= 25-55% Dubberke ER, et al. Infect Control Hosp Epidemiol 2014;35: Trinity Health. All Rights Reserved. 13

14 Collateral Consequences of CDI in Era of Value-Based Purchasing; Readmission Risks Am J Infect Control 2015;43: Trinity Health. All Rights Reserved. 14

15 Clostridium difficile Anaerobic, spore-forming Gram positive bacillus Diseases: pseudomembranous colitis, toxic megacolon, sepsis, and death Fecal-oral transmission through contaminated environment and hands of healthcare personnel Antimicrobial exposure is major risk factor for disease Healthy colon Pseudomembranous colitis

16 Pathogenesis of C. difficile Infection (CDI) Ingestion Germination Proliferation Toxin Production Sunenshine RH, McDonald LC. Cleve Clin J Med. 2006;73: ; with permission.

17 Fig 1. Developmental life cycle of Clostridium difficile during infection. Shen A (2015) A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination. PLoS Pathog 11(10): e doi: /journal.ppat Trinity Health. All Rights Reserved. 17

18 Prerequisites for CDI Cefa getem all Antimicrobial therapy Disturbed colonic microflora Acquisition of toxigenic C. difficile Advanced age Underlying illness Enterotoxin A & cytotoxin B production CDI CDI due to recent (re)acquisition of C. difficile Incubation period unknown <7 days to several weeks? Antimicrobial exposure may or may not precede acquisition The two appear to be in proximity

19 Increased Toxin B Production In Vitro In vitro production of toxins A and B by C. difficile isolates. Median concentration and IQRs are shown. C. difficile strains included 25 toxinotype 0 and 15 NAP1/027 strains (toxinotype III) from various locations. IQR=interquartile range. Adapted from Warny M, et al. Lancet. 2005;366: ; with permission.

20 Laboratory Diagnosis of CDI APIC Implementation Guide: Guide to Preventing CDI, Trinity Health. All Rights Reserved. 20

21 CDC s Vital Signs Report 03/06/2012 Patient: George

22 Transmission Dynamics Model CDI Donskey C. CID 2010:50 (1 June)

23 Prevent the spread Prevention Strategies Antibiotic stewardship (prudent use) Use of contact precautions Environmental cleaning/disinfection Educate: HCWs, patients, family and visitors Prevent cross transmission between patients via the hands of HCW s Put on gloves just before or soon after entering patient s room Emphasize Use of hand hygiene

24 Targeted antibiotic consumption and nosocomial C. difficile disease Tertiary care hospital; Quebec, Valiquette, et al. Clin Infect Dis 2007;45:S112.

25 Impact of Antimicrobial Stewardship Program (ASP) on HAI Outcomes; quarterly Rate of isolates per 10,000 patient days Baseline 8 Quarters mean Post Intervention mean 17 Quarters Difference in Isolates Comparison of Means p-value C. difficile* VRE * MRSA* MSSA* ESBL Pseudomonas Acinetobacter Candida* The changes in isolate values are reflected as either a reduction (negative sign) or increase number. Using Student T-test comparison of the means before and after intervention at p<0.05 *Statistically significant rate reduction per quarter of pathogen isolates per patient days. Madison G, Kleina L, Turco T, Hunter J, Hallur R.; ASP Team, Mercy Philadelphia Hospital, 10/20/15

26 ASP Program Impact: Purchases of Targeted Drugs by Quarter Overall reduction of 74% in targeted drugs purchased. Individual antibiotic percent reduction is as follows: carbapenems (59%), linezolid (85%), piperacillin/tazobactam (77%), vancomycin (54%).

27 ASP Resource Trinity Health. All Rights Reserved. 27

28 When Can Isolation Be Discontinued? Duration of illness; After resolution of symptoms, patients with CDI can continue to shed C. difficile in stool and contaminate the environment. Use for duration of hospital stay = special approach Donskey C. CID 2010:50 (1 June) & SHEA CDI Compendium, 2014

29 Urban Legend? C diff and Hand Hygiene Soap Or Alcohol Hand Rub? What is the most important action to prevent contamination of hands with spores? Is soap and water required for hand hygiene in a C diff room? Does alcohol hand rub increase the rate of Clostridium difficile in the hospital? Wear gloves before entry to the room and remove prior to exiting the room. It is difficult to wash off spores. If hands or gloves are visibly soiled or there is an outbreak. Several studies find that alcohol hand rub does not increase the rate. What happens if there is an outbreak or a high incidence of C diff on a unit? Infection Prevention & control will notify the unit if changes in hand hygiene method are needed. SHEA CDI & Hand Hygiene Compendium, 2014

30 Renewed Respect for Role of the Environment: Prior Room Occupant = Risk of Acquisition Growing evidence on increased risk of acquisition of specific pathogens, C. difficile, MRSA, and VRE, when admitted to room where prior occupant had one of these or if in multi-occupancy room Huang SS (2006) 1 Drees M (2008) 2 Zhou Q (2008) 3 Moore C (2008) 4 Hamel M (2010) 5 Shaughnessy et al. ICHE 2011;32: Huang SS, et al. Arch Intern Med. 2006;166(18): Drees M, et al. Clin Infect Dis. 2008;46(5): Zhou Q, et al. Infect Control Hosp Epidemiol. 2008;29(5): Moore C, et al. Infect Control Hosp Epidemiol. 2008;29(7): Hamel M, et al. Am J Infect Control. 2010;38(3): Trinity Health. All Rights Reserved. 30

31 The Environment Of Care When possible, use dedicated patient-care equipment (e.g., blood pressure cuffs) or If reusable equipment is unavoidable, clean and disinfect equipment before use on another patient Focus on frequently touched surfaces (e.g., bed rails, over bed table, bedside commode, bathrooms surfaces) and equipment in the immediate vicinity of the patient

32 What Do Healthcare Personnel Touch with High FREQUENCY? ICU Setting (N=28) Huslage K, Rutala WA, Sickbert-Bennett E, Weber DJ. ICHE 2010;31:

33 TERMINAL ROOM CLEANING: DEMONSTRATION OF IMPROVED CLEANING Evaluated cleaning before and after an intervention to improve cleaning 36 US acute care hospitals Assessed cleaning using a fluorescent dye Interventions Increased education of environmental service workers Feedback to environmental service workers Regularly change dotted items to prevent targeting objects Carling PC, et al. ICHE 2008;29:

34 Automated, No-Touch Disinfection Vaporized Hydrogen Peroxide Ultraviolet Germicidal Irradiation (UVGI)

35 Comparison of H2O2 vs UVGI NTD NTD = No touch disinfection Emerging evidence; J Hosp Infect 2013;83:1-13 select devices 2014 Trinity Health - Livonia, MI 35

36 Recommended Framework for Assessing Need and Value of No Touch Disinfection (NTD) 1. Review data on frequency of healthcare associated infections (HAIs) does this identify opportunities to improve cleaning/disinfection of the environment? 2. Engage key stakeholders; Environmental Services and Infection Prevention & Control (IPC) leaders to review and assess need + value 3. Apply peer-reviewed, scientific evidence to identify need 4. Is there sufficient infrastructure to operate NTD devices and will this be sustained? 5. What is level of adherence by colleagues and clinicians with other core prevention strategies, e.g. hand hygiene, isolation precautions, antibiotic stewardship, etc.? 2014 Trinity 2014 Health. Trinity All Health Rights - Livonia, Reserved. MI 36

37 No Touch Disinfection? Key questions APIC. Guide to Preventing CDI, 2013

38 Highlights from ID Week, 2015 UVGI was deployed for 21.1% (542/2569) of all patient discharges on the 3 study units Rates of CDI declined 25% on the study units and increased 16% on non-study units during the intervention vs. baseline period Trinity Health. All Rights Reserved. 38

39 Highlights from ID Week, months in 9 study hospitals from 4/2012 to 7/2014 quaternary ammonium (reference group A) compared to 3 enhanced cleaning strategies: quaternary ammonium + UV-C (B), bleach (C), and bleach + UV-C (D). bleach was used for daily and terminal disinfection of all known C. difficile rooms, regardless of study arm. Target pathogens = MRSA, VRE, C. difficile, or MDR Acinetobacter 2014 Trinity Health. All Rights Reserved. 39

40 Highlights from ID Week, 2015 BETR Study, continued all target MDROs was 37% lower in Group B (p=0.03) and 32% lower in Group D (p=0.01) No significant impact on incidence of CDI with UVGI over dilute bleach alone Trinity Health. All Rights Reserved. 40

41 Bundle Approach SHEA CDI Compendium,2014 Limit testing to those with symptoms of CDI do not perform repeat test for cure Prompt identification of suspect case - consider lab-base alert for + Avoid use of electronic thermometers for those with CDI dedicated equipment if possible Contact Precautions; ideally in private rooms Don gown and gloves upon entry to the patient s room Hand hygiene based on CDC or WHO guidelines Ensure cleaning and disinfection of equipment and the environment Sodium hypochlorite (household bleach) diluted 1 : 10 with water or an EPA registered sporicidal product in an outbreak or high rates Surveillance, education providers and patients Special approaches: risk assessment then Data are currently too limited to draw any conclusions as to whether or when these devices should be a component of a CDI prevention program. In addition, excellent results can be achieved with manual cleaning with a sporicidal disinfectant 2014 Trinity 2014 Health. Trinity All Health Rights - Livonia, Reserved. MI 41

42 CDI Prevention Strategies; Use and Perception of Strength of Supporting Evidence, U.S. Hospitals Saint S, et al. Infect Control Hosp Epidemiol 2015;36: Trinity Health. All Rights Reserved. 42

43 Reality Check; Back to Basics & Human Factors Full compliance with Contact Precautions (CP) for CDI was low at 2 different hospitals Adherence with CP for CDI is a complex, timeconsuming process Need human factors engineering approach to improve Yanke E, et al. Am J Infect Control 2015;43: Trinity Health. All Rights Reserved. 43

44 CDI Prevention in GA?: Ahead of the curve by leaps & bounds Trinity Health. All Rights Reserved. 44

45 Bundle Approach to Prevention & Control of CDI GHA LEAPT/GAPP Meeting, 6/12/ Trinity Health. All Rights Reserved. 45

46 2014 Trinity Health. All Rights Reserved. 46

47 Fecal microbiota transplants (FMT) FMT has demonstrated extraordinary clinical resolution, C. difficile infection cure rates of over 90%, and low recurrence [Borody T, et al. Expert Rev Gastroenterol Hepatol Sep 28:1-13] One option; Open Biome Trinity 2014 Health. Trinity All Health Rights - Livonia, Reserved. MI 47

48 Risk Based Planning Risk Assessment Infection risk assessment IC Evaluation IC Implementation IC Risks IC Goals Goal Reduce or eliminate infection Implementation Based on guidelines and organizationspecific risk Evaluation Rates reduced? Best practices followed? Implementation complete? D. Rumovitz St. Mary Medical Ctr, Langhorne, PA; Spring 2014 ART Conference

49 Thank You. Discussion/Questions 2014 Trinity Health. All Rights Reserved. 49

C Difficile - The Ultimate Challenge: Controlling the Spread

C Difficile - The Ultimate Challenge: Controlling the Spread C Difficile - The Ultimate Challenge: Controlling the Spread Linda R. Greene, RN, MPS, CIC Manager of Infection Prevention Highland Hospital Rochester, NY University of Rochester Medical Center linda_greene@urmc.rochester.edu

More information

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH Some history first Clostridium difficile, a spore-forming gram-positive (i.e., thick

More information

6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations

6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations CLOSTRIDIUM DIFFICILE PREVENTION Beth Goodall, RN, BSN Board Certified in Infection Prevention and Control DCH Health System Epidemiology Director Welcome! Teaming Up to Prevent Infections! CLOSTRIDIUM

More information

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE

More information

Clostridium difficile Essential information

Clostridium difficile Essential information Clostridium difficile Essential information Clostridium difficile Origins Clostridium difficile (C. diff) is a Gram positive, spore forming, anaerobic bacterium with a rod structure. It was first identified

More information

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated

More information

Clostridium difficile Infection: Diagnosis and Management

Clostridium difficile Infection: Diagnosis and Management Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,

More information

Clostridium difficile: An Overview

Clostridium difficile: An Overview Clostridium difficile: An Overview CDI Webinar July 11, 2017 PUBLIC HEALTH DIVISION Acute and Communicable Disease Prevention Section Outline Background Microbiology Burden Pathogenesis Diagnostic testing

More information

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual

More information

Los Angeles County Department of Public Health: Your Partner in CDI Prevention

Los Angeles County Department of Public Health: Your Partner in CDI Prevention Los Angeles County Department of Public Health: Your Partner in CDI Prevention Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health dterashita@ph.lacounty.gov

More information

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers

CDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers Disclosures No conflict of interest to declare Acknowledgments Objectives and Agenda Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Guidelines

More information

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection

More information

Clostridium difficile infection surveillance: Applying the case definition

Clostridium difficile infection surveillance: Applying the case definition Clostridium difficile infection surveillance: Applying the case definition PICNet Conference March 3 rd 2016 Presented by: Tara Leigh Donovan, MSc Managing Consultant (Former Epidemiologist) 1 Disclaimer

More information

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment. C. DIFFICILE Case definition CONFIRMED CASE A patient is defined as a case if they are one year of age or older AND have one of the following requirements: A laboratory confirmation of a positive toxin

More information

C. difficile: The Changing Epidemiology Evaluations Clostridium difficile Thank You to our Sponsors

C. difficile: The Changing Epidemiology Evaluations Clostridium difficile Thank You to our Sponsors C. difficile: The Changing Epidemiology Ghinwa Dumyati, MD University of Rochester Monroe County Department of Public Health Thank You to our Sponsors Evaluations School of Public Health, University at

More information

EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI)

EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics & Epidemiology Associate Chief Medical Offer, UNC Health Care Medical

More information

Room decontamination (UV, HPV, others): An update

Room decontamination (UV, HPV, others): An update Room decontamination (UV, HPV, others): An update Curtis Donskey, M.D. Louis Stokes VA Medical Center Cleveland, Ohio Disclosure: Research support from Pfizer, Merck, Clorox, GOJO, Avery Dennison, PDI

More information

Principles and Practices of Asepsis

Principles and Practices of Asepsis Module E Objectives Principles and Practices of Asepsis Role of hands and the environment in disease transmission Describe the principles and practice of asepsis Understand hand hygiene Understand the

More information

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?

Case 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Case 1 21 yr old HIV +ve, Cd4-100 HAART naïve Profuse diarrhoea for 3/52. Stool MC&S ve Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Repeat stool MC&S Stool

More information

Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening

Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening There s an updated Annex C Annex C is an extension to the PIDAC Infection Prevention

More information

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose?

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? March 9, 0 http://www.slh.wisc.edu/outreach-data/event-detail.php?id=03 Raymond P. Podzorski, Ph.D., D(ABMM) Clinical Microbiologist

More information

Prevention and Control of Healthcare-Associated Norovirus

Prevention and Control of Healthcare-Associated Norovirus Purpose: Audience: Policy: To prevent healthcare-associated norovirus infections in patients, employees, contract workers, volunteers, visitors and students and to control and eradicate norovirus infections

More information

Activity C: ELC Prevention Collaboratives

Activity C: ELC Prevention Collaboratives Clostridium difficile il (CDI) Infections Toolkit Activity C: ELC Prevention Collaboratives Carolyn Gould, MD MSCR Cliff McDonald, MD, FACP Division of Healthcare Quality Promotion Centers for Disease

More information

VIII Congresso Nazionale Maggio 2018

VIII Congresso Nazionale Maggio 2018 VIII Congresso Nazionale Attualità e prospettive nella prevenzione e controllo delle infezioni nelle organizzazioni sanitarie 21-23 Maggio 2018 Bergamo, Ospedale Papa Giovanni XXIII Clostridium difficile

More information

Probiotics for Primary Prevention of Clostridium difficile Infection

Probiotics for Primary Prevention of Clostridium difficile Infection Probiotics for Primary Prevention of Clostridium difficile Infection Objectives Review risk factors for Clostridium difficile infection (CDI) Describe guideline recommendations for CDI prevention Discuss

More information

ABSTRACT PURPOSE METHODS

ABSTRACT PURPOSE METHODS ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection

More information

Modern approach to Clostridium Difficile Infection

Modern approach to Clostridium Difficile Infection Modern approach to Clostridium Difficile Infection Pseudomembranous Colitis: Principles for diagnosis and treatment Aggelos Stefos Internist, Infectious diseases Specialist Department of Medicine and Research

More information

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer

Journey to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical

More information

Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela

Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Chapter 19 Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Key Points Noroviruses are the commonest cause of healthcare-associated gastroenteritis. Isolation

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known

More information

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES

CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES CONTROL OF VIRAL GASTROENTERITIS OUTBREAKS IN CALIFORNIA LONG-TERM CARE FACILITIES California Department of Health Services Division of Communicable Disease Control In Conjunction with Licensing and Certification

More information

Getting to Know You. Tackling Clostridium difficile in Nursing Homes. Outline. C. difficile Epidemiology 11/18/2013

Getting to Know You. Tackling Clostridium difficile in Nursing Homes. Outline. C. difficile Epidemiology 11/18/2013 Tackling Clostridium difficile in Nursing Homes Getting to Know You Emily Lutterloh, MD, MPH Director, Bureau of Healthcare Associated Infections New York State Department of Health Outline Getting to

More information

Preventing & Controlling the Spread of Infection

Preventing & Controlling the Spread of Infection Preventing & Controlling the Spread of Infection Contributors: Alice Pong M.D., Hospital Epidemiologist Chris Abe, R.N., Senior Director Ancillary and Support Services Objectives Review the magnitude of

More information

Guidelines for the Control of a Suspected or Confirmed Outbreak of Viral Gastroenteritis (Norovirus) in an Assisted Living Facility or Nursing Home

Guidelines for the Control of a Suspected or Confirmed Outbreak of Viral Gastroenteritis (Norovirus) in an Assisted Living Facility or Nursing Home Guidelines for the Control of a Suspected or Confirmed Outbreak of Viral Gastroenteritis (Norovirus) in an Assisted Living Facility or Nursing Home The following is a summary of guidelines developed to

More information

Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo

Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo Istituto Nazionale per le Malattie Infettive «lazzaro Spallanzani», IRCCS-Roma The infectious cycle of transmission

More information

Does Improving Surface Cleaning and Disinfection Reduce HAI? Prof. William Rutala, University of North Carolina A Webber Training Teleclass

Does Improving Surface Cleaning and Disinfection Reduce HAI? Prof. William Rutala, University of North Carolina A Webber Training Teleclass AD Russell Memorial Teleclass Does Improving Surface Cleaning and Disinfection Reduce Healthcare-Associated Infections? The A. Denver Russell Memorial Teleclass Lecture (2013) William A. Rutala, PhD, MPH

More information

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit

DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit GASTROENTERITIS DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest within this presentation fidaxomicin (which

More information

Clostridium difficile Infection (CDI) Management Guideline

Clostridium difficile Infection (CDI) Management Guideline Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Care Homes IPC Study Day Sue Barber Infection Prevention & Control Lead AV & Chiltern CCG s Clostridium difficile A spore forming Bacterium. Difficult to grow in the laboratory hence

More information

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click

More information

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI) Clostridium Difficile: Updates on Diagnosis and Treatment Elizabeth Hudson, DO, MPH 9/25/18 Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics In

More information

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI L. Clifford McDonald, MD Lance R. Peterson, MD March 27, 2012 1 Potential COI L. Clifford McDonald,

More information

Lourdes Hospital Infection Prevention and Control

Lourdes Hospital Infection Prevention and Control Lourdes Hospital Infection Prevention and Control Lourdes Infection Prevention Program Ultimate goal: To protect the patient To protect the healthcare workers, visitors and others in the environment To

More information

C. difficile and the Environment: Disinfection Practices and Mitigating Risk to Patients

C. difficile and the Environment: Disinfection Practices and Mitigating Risk to Patients C. difficile and the Environment: Disinfection Practices and Mitigating Risk to Patients William A. Rutala, Ph.D., M.P.H. Director, Hospital Epidemiology, Occupational Health and Safety, UNC Health Care;

More information

Evidenced-based Success for HAI Reduction using UV Disinfection. Sponsored by:

Evidenced-based Success for HAI Reduction using UV Disinfection. Sponsored by: Evidenced-based Success for HAI Reduction using UV Disinfection Sponsored by: Speakers - Disclosures Presenter: Alice Brewer, MPH, CIC Director Clinical Affairs John H. C. diff Survivor in California If

More information

2019 UPDATE 1/9/ ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS. Healthcare-Associated Infections (HAIs) INFECTION PREVENTION and CONTROL

2019 UPDATE 1/9/ ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS. Healthcare-Associated Infections (HAIs) INFECTION PREVENTION and CONTROL DC* DC* 219 UPDATE INFECTION PREVENTION and CONTROL Healthcare-Associated Infections (HAIs) ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS Catherine D. Bacheller, M.D. Medical Director, KMC & GVMC Infection

More information

A Pharmacist Perspective

A Pharmacist Perspective Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed

More information

Infection Prevention and Control - General Orientation

Infection Prevention and Control - General Orientation Infection Prevention and Control - General Orientation Hand Hygiene-CDC Isolation Precautions - CDC Medical Waste - OSHA Environmental Cleaning - CDC Safe Injection Practices - CDC Bloodborne Pathogens

More information

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection

Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection Issue Date: June 2013 Vol. 8 No. 6 Author: Amy Marinski, MSN, RN, CCRN, CNL More than 3 million new cases of Clostridium

More information

2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key

2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key Name: School: Instructor: Date: 2017 Infection Prevention and Control/Flu/TB/Basics Test Answer Key For questions about this test, contact Infection Prevention and Control at 678-312-3308. 1. When do you

More information

The epidemiology of Clostridium difficile infection (CDI) in hospitals, longterm care and the community. J Scott Weese DVM DVSc DipACVIM

The epidemiology of Clostridium difficile infection (CDI) in hospitals, longterm care and the community. J Scott Weese DVM DVSc DipACVIM The epidemiology of Clostridium difficile infection (CDI) in hospitals, longterm care and the community J Scott Weese DVM DVSc DipACVIM C. difficile Gram positive anaerobic sporeforming bacterium first

More information

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) What is Clostridium difficile? Clostridium difficile is a Gram-positive anaerobic spore forming bacillus. It is ubiquitous in nature and

More information

Infection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB

Infection control in Aged Residential Care Facilities. Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB Infection control in Aged Residential Care Facilities Dr Sally Roberts Clinical Advisor for IP&C Service, ADHB Background Endemic infections Epidemic infections Managing outbreaks Administrative measures

More information

Clostridioides difficile Infection: What s the BIG Stink?

Clostridioides difficile Infection: What s the BIG Stink? Clostridioides difficile Infection: What s the BIG Stink? GLORIA MATHIS, RN, BSN, CIC 29 TH ANNUAL MEDICAL SURGICAL CONFERENCE APRIL 4, 2019 SAN FRANCISCO, CA I am sre my patient has C. diff. I cold smell

More information

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections Christina M. Surawicz, MD 1, Lawrence J. Brandt, MD 2, David G. Binion, MD 3, Ashwin N. Ananthakrishnan,

More information

Clostridium difficile Infection (CDI)

Clostridium difficile Infection (CDI) 18.09.10 월요집담회 Clostridium difficile Infection (CDI) R4 송주혜 Clostridium difficile infection (CDI) Anaerobic gram (+), spore-forming, toxin(tcda&tcdb)-producing bacillus Transmitted among humans through

More information

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure

Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Clostridium DifficileInfection & Readmissions: An ounce of prevention is worth a pound of cure Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma

More information

SARS Infection Control in Healthcare Settings

SARS Infection Control in Healthcare Settings SARS Infection Control in Healthcare Settings William A. Rutala, Ph.D., M.P.H. University of North Carolina (UNC) Hospitals and UNC School of Medicine Infection Control Considerations Hospitals must protect

More information

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile

HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile OBJECTIVES HEALTHCARE- ASSOCIATED INFECTIONS: A FOCUS ON Clostridium difficile Identify and describe the pathophysiology of C. diff. Identify and describe current therapies in treatment of C. diff Identify

More information

Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures?

Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures? Clostridium difficile Infection (CDI) What is it? Modes of transmission? Environmental Sources? Control Measures? Clostridium difficile Clostridium difficile - first described in 1935 when it was isolated

More information

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Clostridium Difficile Associated Disease Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Introduction Which of the following is more common in community hospitals in the Southeast

More information

Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others

Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 48 Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others Authors Olivier Vandenberg, MD, PhD Michèle

More information

Norovirus Outbreak in a Children s Hospital. Jennifer Adams, MT, MPH, CIC April 23, 2015

Norovirus Outbreak in a Children s Hospital. Jennifer Adams, MT, MPH, CIC April 23, 2015 Norovirus Outbreak in a Children s Hospital Jennifer Adams, MT, MPH, CIC April 23, 2015 Objectives Discuss the epidemiology, symptoms, and transmission of norovirus. Identify key infection control activities

More information

Patient Safety Summit 2014

Patient Safety Summit 2014 Patient Safety Summit 2014 The War on C Diff Mark Mellow, MD + C Diff The Organism Gram + bacillus Anaerobic Spore forming Intestinal flora (up to 35% hospitalized patients, 3% of healthy adults) Leading

More information

No-touch room disinfection (NTD) systems: when to use them and how to choose between them

No-touch room disinfection (NTD) systems: when to use them and how to choose between them No-touch room disinfection (NTD) systems: when to use them and how to choose between them (Can you C the difference?) APIC New England, April 24 2014 Jon Otter, PhD Scientific Director, Healthcare, Bioquell

More information

The Year in Infection Control

The Year in Infection Control The Year in Infection Control Andie Lee Departments of Infectious Diseases and Microbiology Royal Prince Alfred Hospital Sydney, Australia 1 1.223 million Pubmed publications last 12 months 2 Selection

More information

Sources of Pathogens Causing Healthcare-Associated Infections

Sources of Pathogens Causing Healthcare-Associated Infections The Role of the Environment in Transmission of Healthcare-Associated Infections, No-Touch Methods to Decontaminate the Environment, and When and How to Culture the Environment John M. Boyce, MD Director,

More information

2018 UPDATE. INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS

2018 UPDATE. INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS 2018 UPDATE INFECTION PREVENTION and CONTROL ISOLATION PRECAUTIONS & BLOODBORNE PATHOGENS Catherine D. Bacheller, M.D. Medical Director, KMC & GVMC Infection Prevention and Control Assistant Professor

More information

Safe Patient Care Keeping our Residents Safe

Safe Patient Care Keeping our Residents Safe Safe Patient Care Keeping our Residents Safe 2016 Diarrhoea & Vomiting Infection Prevention & Control in Residential Care Setting Patricia Coughlan, Infection Prevention Control Nurse, HSE Disability Services

More information

Infection Prevention & Control Core Skills Level 2

Infection Prevention & Control Core Skills Level 2 Infection Prevention & Control Core Skills Level 2 Learning outcomes Risk assessment of patients Critical examination of the situation MRSA, CDT & CPE Ongoing challenges future-proofing infection control

More information

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary Course: Patient Safety Solutions Topic: Infection prevention and control Summary Health care-associated Infection (HCAI) is defined as an infection acquired in a hospital by a patient who was admitted

More information

Dr. Linda D. Lee Chief Science Officer VidaShield

Dr. Linda D. Lee Chief Science Officer VidaShield Dr. Linda D. Lee Chief Science Officer VidaShield Room-based active UV-C technology reduces the amount of bacteria and/or fungus in the air and improves indoor air quality. 1. Describe at least three instances

More information

Understanding C. diff. atomalliance.org/cdifftraining

Understanding C. diff. atomalliance.org/cdifftraining Understanding C. diff atomalliance.org/cdifftraining This booklet is a printed guide of the online educational resource atomalliance.org/cdifftraining Target Audience Understanding C. diff This educational

More information

An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings

An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings About APIC APIC s mission is to improve health and patient safety by reducing risks of infection and other adverse

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Infection Control Team Patient Information Leaflet What is Clostridium difficile? Clostridium difficile (sometimes called C. diff) is a type of bacteria. They live in the intestine

More information

Healthcare-Associated Infections Across the Spectrum of Care

Healthcare-Associated Infections Across the Spectrum of Care MODULE 9: HEALTHCARE-ASSOCIATED INFECTIONS ACROSS THE SPECTRUM OF CARE Healthcare-Associated Infections Across the Spectrum of Care Susan E. Coffin, MD, MPH UPENN School of Medicine, Department of Pediatrics

More information

OBJECTIVES PEOPLE AS RESERVOIRS. Reservoir

OBJECTIVES PEOPLE AS RESERVOIRS. Reservoir Module C EPIDEMIOLOGY AND RISK OF INFECTION IN OUTPATIENT SETTINGS Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine OBJECTIVES Discuss the infectious process Review

More information

Before an outbreak - what to do after first MDR Gram-negatives enter your hospital?

Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London j.otter@imperial.ac.uk @jonotter Blog: www.reflectionsipc.com Slides:

More information

Infection Control Standard Precautions and Isolation

Infection Control Standard Precautions and Isolation Infection Control Standard Precautions and Isolation Michael Bell, M.D. Division of Healthcare Quality Promotion Centers for Disease Control and Prevention History of Infection Control Precautions in the

More information

PANDEMIC INFLUENZA PHASE 6 INFECTION CONTROL RECOMMENDATIONS TEMPLATE

PANDEMIC INFLUENZA PHASE 6 INFECTION CONTROL RECOMMENDATIONS TEMPLATE PANDEMIC INFLUENZA PHASE 6 INFECTION CONTROL RECOMMENDATIONS TEMPLATE (Updated September 7, 2006) Information and concept courtesy Of the San Francisco Public Health Department Table of Contents Pandemic

More information

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015 Controversies and Current Issues in Diagnosis, Surveillance, and Treatment of Clostridium difficile infeciton L. Clifford McDonald, MD Senior Advisor for Science and Integrity September 16, 2015 Division

More information

ISOLATION PRECAUTIONS AND MANAGEMENT OF MULTIDRUG-RESISTANT ORGANISMS (MDROS) IN LONG-TERM CARE FACILITIES. Evelyn Cook, RN, CIC Associate Director

ISOLATION PRECAUTIONS AND MANAGEMENT OF MULTIDRUG-RESISTANT ORGANISMS (MDROS) IN LONG-TERM CARE FACILITIES. Evelyn Cook, RN, CIC Associate Director ISOLATION PRECAUTIONS AND MANAGEMENT OF MULTIDRUG-RESISTANT ORGANISMS (MDROS) IN LONG-TERM CARE FACILITIES Evelyn Cook, RN, CIC Associate Director OBJECTIVES Review Isolation Precautions Review how Multi-drug

More information

Hand Hygiene for Clinical Staff

Hand Hygiene for Clinical Staff Hand Hygiene for Clinical Staff Volunteer Annual Review 2017 Why All the Fuss About Hand Hygiene? Most common mode of transmission of pathogens is via hands! What is Hand Hygiene? Hand Hygiene means cleaning

More information

Health Care Nosocomial Infections NASA CHMO Occupational Health Conference April 18, 2013 NASA KSC

Health Care Nosocomial Infections NASA CHMO Occupational Health Conference April 18, 2013 NASA KSC Health Care Nosocomial Infections 2013 NASA CHMO Occupational Health Conference April 18, 2013 NASA KSC 1 Disclosure No competing conflicts of interested Resources provided by CSIMPP/SPP Update 2 2 Warning

More information

Clostridium difficile Infections

Clostridium difficile Infections Educational Module for Nurses in Long-term Care Facilities: Preventing and Managing Clostridium difficile Infections Clostridium difficile (C. difficile) causes a wide range of illness - from uncomplicated

More information

Sustained Antimicrobial Activity of a Novel Disinfectant Against Healthcare Pathogens

Sustained Antimicrobial Activity of a Novel Disinfectant Against Healthcare Pathogens Sustained Antimicrobial Activity of a Novel Disinfectant Against Healthcare Pathogens William A. Rutala, PhD, MPH, Maria F. Gergen MT (ASCP), Emily E. Sickbert-Bennett, PhD, Deverick J. Anderson, MD, MPH,

More information

Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection

Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection Christopher R. Polage, MD, MAS Associate Professor of Pathology and Infectious Diseases UC Davis Disclosures Test materials

More information

Can We Prevent All Healthcare- Associated Clostridium difficile infections in 10 Years?

Can We Prevent All Healthcare- Associated Clostridium difficile infections in 10 Years? Can We Prevent All Healthcare- Associated Clostridium difficile infections in 10 Years? Curtis Donskey, M.D. Louis Stokes VA Medical Center Cleveland, Ohio Research support: Clorox, EcoLab, GOJO, Merck,

More information

ISOLATION PRECAUTIONS. Karen Hoffmann RN, MS, CIC, FSHEA, FAPIC

ISOLATION PRECAUTIONS. Karen Hoffmann RN, MS, CIC, FSHEA, FAPIC ISOLATION PRECAUTIONS Karen Hoffmann RN, MS, CIC, FSHEA, FAPIC 2006 Management Of Resistant O In Healthcare Settings 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents

More information

Infection Control Assessment and Response (ICAR) in Long-term Care

Infection Control Assessment and Response (ICAR) in Long-term Care Infection Control Assessment and Response (ICAR) in Long-term Care Carol Genese, MBA ICAR Infection Preventionist Communicable Disease Service New Jersey Department of Health Agenda ICAR Introduction ICAR

More information

CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08

CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08 CONSUMERS UNION POLICY BRIEF HOSPITAL-ACQUIRED C. DIFFICILE INFECTIONS (CDI) 11-08 The growth of infections caused by Clostridium difficile (C.diff) is a highly alarming trend in hospitals today. In 1993

More information

Impact of hospital infections on our

Impact of hospital infections on our Impact of hospital infections on our ageing population Professor Peter Lambert School of Life and Health Sciences P. A. Lambert Slides are for personal use only. They are NOT for reproduction or publication

More information

TITLE OF PRESENTATION

TITLE OF PRESENTATION TITLE OF PRESENTATION Can C. Subtitle difficile of Infection Presentation Rates Be Used to Judge Prevention Success for Hospitals? David P. Calfee, MD, MS Associate Professor of Medicine and Public Health

More information

EVALUATING OXIVIR TB VERSUS CRITERIA OF IDEAL DISINFECTANTS HOW DOES IT STACK UP?

EVALUATING OXIVIR TB VERSUS CRITERIA OF IDEAL DISINFECTANTS HOW DOES IT STACK UP? EVALUATING OXIVIR TB VERSUS CRITERIA OF IDEAL DISINFECTANTS HOW DOES IT STACK UP? Recent studies have demonstrated that the environment plays a role in the transmission of healthcare-associated infections

More information

Conference For Healthcare Transparency & Patient Safety. Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015

Conference For Healthcare Transparency & Patient Safety. Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015 Conference For Healthcare Transparency & Patient Safety Kraig Humbaugh, MD, MPH Lexington, KY November 13, 2015 2 Objectives After this presentation, participants will be able to: Explain the importance

More information

Risk-Assessment Worksheet

Risk-Assessment Worksheet Risk-Assessment Worksheet Issue: Off-label use of one minute contact times for low-level surface disinfectants used on noncritical environmental surfaces and noncritical patient care equipment. Assessment

More information

TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION

TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION HOW TB IS SPREAD GENERATION OF TB DROPLET NUCLEI One cough produces 500 droplets Average TB patient generates 75,000 droplets/day (before

More information

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Objectives Summarize the changing epidemiology and demographics of patients at risk for Clostridium

More information

Self-Instructional Packet (SIP)

Self-Instructional Packet (SIP) Self-Instructional Packet (SIP) Advanced Infection Prevention and Control Training Module 1 Intro to Infection Prevention Control February 11, 2013 Page 1 Learning Objectives Module One Introduction to

More information

2018 Ascension Infection Prevention. 1. Course. 1.1 Infection Prevention. 1.2 Main Objectives

2018 Ascension Infection Prevention. 1. Course. 1.1 Infection Prevention. 1.2 Main Objectives 2018 Ascension Infection Prevention 1. Course 1.1 Infection Prevention 1.2 Main Objectives Additional Objectives Understand the purpose of the Corporate Responsibility Program State examples of expected

More information